跳转至内容
Merck
CN
  • The use of doubly labeled milk protein to measure postprandial muscle protein synthesis rates in vivo in humans.

The use of doubly labeled milk protein to measure postprandial muscle protein synthesis rates in vivo in humans.

Journal of applied physiology (Bethesda, Md. : 1985) (2014-10-04)
Nicholas A Burd, Naomi M Cermak, Imre W K Kouw, Stefan H Gorissen, Annemie P Gijsen, Luc J C van Loon
摘要

We aimed to determine the impact of precursor pool dilution on the assessment of postprandial myofibrillar protein synthesis rates (MPS). A Holstein dairy cow was infused with large amounts of L-[1-(13)C]phenylalanine and L-[1-(13)C]leucine, and the milk was collected and fractionated. The enrichment levels in the casein were 38.7 and 9.3 mole percent excess, respectively. In a subsequent human experiment, 11 older men (age: 71 ± 1 y, body mass index: 26 ± 0.1 kg·m(-2)) received a primed constant infusion of L-[ring-(2)H5]phenylalanine and L-[1-(13)C]leucine. Blood and muscle samples were collected before and after the ingestion of 20-g doubly labeled casein to assess postprandial MPS based on the 1) constant tracer infusion of L-[ring-(2)H5]phenylalanine, 2) ingestion of intrinsically L-[1-(13)C]phenylalanine-labeled casein, and 3) constant infusion of L-[1-(13)C]leucine in combination with the ingestion of intrinsically L-[1-(13)C]leucine-labeled casein. Postprandial MPS was increased (P < 0.05) after protein ingestion (∼70% above postabsorptive values) based on the L-[1-(13)C]leucine tracer. There was no significant stimulation of postprandial MPS (∼27% above postabsorptive values) when the calculated fractional synthesis rate was based on the L-[ring-(2)H5]phenylalanine (P = 0.2). Comparisons of postprandial MPS based on the primed continuous infusion of L-[1-(13)C]leucine or the ingestion of intrinsically L-[1-(13)C]phenylalanine-labeled casein protein demonstrated differences compared with the primed continuous infusion of L-[ring-(2)H5]phenylalanine (P > 0.05). Our findings confirm that the postprandial MPS assessed using the primed continuous tracer infusion approach may differ if tracer steady-state conditions in the precursor pools are perturbed. The use of intrinsically doubly labeled protein provides a method to study the metabolic fate of the ingested protein and the subsequent postprandial MPS response.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
氢氧化铵 溶液, ACS reagent, 28.0-30.0% NH3 basis
Sigma-Aldrich
乙酸, glacial, ACS reagent, ≥99.7%
Sigma-Aldrich
乙酸, glacial, ReagentPlus®, ≥99%
Sigma-Aldrich
氢氧化铵 溶液, 28% NH3 in H2O, ≥99.99% trace metals basis
Sigma-Aldrich
乙酸, glacial, ≥99.99% trace metals basis
Sigma-Aldrich
乙酸 溶液, suitable for HPLC
Sigma-Aldrich
乙酸, glacial, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8%
Sigma-Aldrich
乙酸, glacial, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
Sigma-Aldrich
氢氧化铵 溶液, puriss., 30-33% NH3 in H2O
Sigma-Aldrich
氢氧化铵 溶液, puriss. p.a., reag. ISO, reag. Ph. Eur., ~25% NH3 basis
Sigma-Aldrich
乙酸, suitable for luminescence, BioUltra, ≥99.5% (GC)
USP
冰醋酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
氢氧化铵 溶液, BioUltra, ~1 M NH3 in H2O (T)
Supelco
乙酸, analytical standard
Sigma-Aldrich
氢氧化铵 溶液, puriss., meets analytical specification of Ph. Eur., 25-30% NH3 basis
Sigma-Aldrich
乙酸, ≥99.5%, FCC, FG
Sigma-Aldrich
乙酸, natural, ≥99.5%, FG
Sigma-Aldrich
氢氧化铵 溶液, puriss. p.a. plus, ≥25% NH3 in H2O
Sigma-Aldrich
乙酸, glacial, puriss., 99-100%
Sigma-Aldrich
DL-苯丙氨酸, ReagentPlus®, 99%
亮氨酸, European Pharmacopoeia (EP) Reference Standard
苯丙氨酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
DL-亮氨酸, ≥99% (HPLC)
Supelco
5α-雄甾烷-17β-醇-3-酮, VETRANAL®, analytical standard
Sigma-Aldrich
乙酸-12C2, 99.9 atom % 12C
Millipore
Bifido 选择性添加剂 B, suitable for microbiology